B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies

The contributions of the humoral immune response to melanoma are now widely recognized, with reports of positive prognostic value ascribed to tumor-infiltrating B cells (TIL-B) and increasing evidence of B cells as key predictors of patient response to treatment. There are disparate views as to the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Willsmore, Zena N., Harris, Robert J., Crescioli, Silvia, Hussein, Khuluud, Kakkassery, Helen, Thapa, Deepika, Cheung, Anthony, Chauhan, Jitesh, Bax, Heather J., Chenoweth, Alicia, Laddach, Roman, Osborn, Gabriel, McCraw, Alexa, Hoffmann, Ricarda M., Nakamura, Mano, Geh, Jenny L., MacKenzie-Ross, Alastair, Healy, Ciaran, Tsoka, Sophia, Spicer, James F., Papa, Sophie, Barber, Linda, Lacy, Katie E., Karagiannis, Sophia N.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7868381/
https://ncbi.nlm.nih.gov/pubmed/33569063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.622442
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados